Dismissing patient, family, and caregiver concerns is the biggest threat to patient safety, according to ECRI. The organization said that time and resource constraints are making it increasingly difficult for health care providers to address patient concerns.
APhA staff
Preliminary data suggest that CDC’s recommendation that all qualified persons 6 months and older receive a 2024–2025 COVID-19 vaccination was an effective move.
On February 4, 2025, FDA approved Onapgo (apomorphine hydrochloride), a wearable infusion device, available soon in the United States for adults with advanced Parkinson’s disease.
On January 6, 2025, FDA published new draft guidance aimed at helping improve the accuracy and performance of pulse oximeters.
While previously published findings pointed to a decline in adherence to cardiovascular drug regimens following community pharmacy closures, new research suggests a similar pattern with anticonvulsants.